Gorman-Rupp (GRC) moved into focus after Zacks upgraded the stock to a Rank #2, citing rising earnings estimates that are drawing fresh attention from institutions and retail investors alike.
Recent trading has been choppy for Gorman-Rupp, with the share price down 16.85% over the past 90 days and 4.39% over the last month. It is still up 54.15% year to date, while the 1-year total shareholder return sits at 63.51% and the 3-year figure at 137.56%, pointing to strong longer term momentum despite the pullback.
Extend your Gorman-Rupp research by scanning a curated set of industrial peers and other earnings-driven stories through 16 high quality undiscovered gems in the same corner of the market.
After a near 17% pullback in 90 days but a 54% gain year to date, Gorman-Rupp now forces a simple choice. Is this the moment to pay up, or is it better to wait for a cleaner valuation entry?
Preferred P/E of 31.4x: Is it justified?
Gorman-Rupp now trades on a P/E of 31.4x, which the data suggests lines up with peers on one measure but looks stretched on others at a $74.21 share price.
The P/E ratio compares the current share price to earnings per share and gives a quick sense of how much investors are paying for each dollar of profit. For an industrial manufacturer like Gorman-Rupp, where earnings and cash generation are central to the story, that lens often carries more weight than revenue based multiples.
Relative to a selected peer group average of 32.8x, Gorman-Rupp is flagged as good value, which implies the market is not assigning a premium to its earnings compared with those peers. Against the broader US Machinery industry on 24.3x, the same 31.4x multiple looks expensive, and compared with an estimated fair P/E of 22.3x it is materially higher. That fair ratio level is a benchmark the valuation could move toward if expectations cool or earnings progress does not keep pace.
Explore the SWS fair ratio for Gorman-Rupp.
Result: Price-to-Earnings of 31.4x (OVERVALUED)
Still, Gorman-Rupp faces pressure if earnings growth slows or industrial demand cools, which could make that 31.4x P/E a tougher hurdle for buyers.
Find out about the key risks to this Gorman-Rupp narrative.
Another View on Gorman-Rupp: What the DCF Says
The P/E math paints Gorman-Rupp as expensive, yet the SWS DCF model points the other way. At a share price of $74.21 versus an estimated future cash flow value of $115.43, the stock screens as undervalued by about 36%. That gap raises a simple question: Is the cash flow story more important to you than the earnings multiple?
Look into how the SWS DCF model arrives at its fair value.
Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Gorman-Rupp for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 32 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.
Next Steps
Mixed signals around Gorman-Rupp's valuation and cash flows create a clear decision point. Move quickly, review the underlying numbers yourself, then weigh both sides of the story through 3 key rewards and 2 important warning signs
Looking for more Gorman-Rupp style investment ideas?
If Gorman-Rupp has sharpened your focus on quality and pricing power, do not stop with a single ticker. Use targeted screens to surface other potential opportunities that fit your approach.
- Target resilient cash generators with supportive valuations by scanning a focused set of 32 high quality undervalued stocks that may align more closely with your price discipline.
- Prioritise staying paid while you wait by reviewing a curated group of income-focused opportunities through the 8 dividend fortresses that offer substantial yields.
- Strengthen your downside protection by filtering for sturdier balance sheets using a list of solid balance sheet and fundamentals (24 results) that highlights companies with financial cushions.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com